Published in:
Open Access
01-11-2012 | Meeting abstract
Fighting for the cures of rare genetic diseases: worthy ideas and promising results demand for strategic research management and for integration of competences and efforts
Author:
Francesca Sofia
Published in:
Orphanet Journal of Rare Diseases
|
Special Issue 2/2012
Login to get access
Excerpt
The fight against genetic diseases, whose aim is the amelioration of the quality and prospect of life of the patients, poses enormous challenges due to several well-known issues such as the rarity of the diseases, the scarcity of financial resources and the lack of knowledge/interest from major stakeholders of the healthcare sector. To cope with this complex and multifaceted problem, in 1990 a patient association in Italy (UILDM) founded Telethon whose mission is to advance scientific research on muscular dystrophy and all other genetic diseases with the ultimate goal of paving the way for the cures. To this end, Telethon has set an articulated strategy whose pillars are: strategic funding of science, selection of the most promising and worthy research ideas, efficient management of funded projects and exploitation of research results. Indeed, in 22 years of activity, Telethon has invested about 354 million Euros, funding 2,375 projects on more than 450 genetic diseases. Notably, Telethon research spans all steps of the research path from the most basic and preliminary phases to the clinical translation, and is increasing our understanding of many genetic diseases, as demonstrated by a wealth of high impact publications. Moreover, clinical trials for different diseases are on-going or in the process to start. …